179 related articles for article (PubMed ID: 38342377)
21. Increased unsaturated lipids underlie lipid peroxidation in synucleinopathy brain.
Fu Y; He Y; Phan K; Bhatia S; Pickford R; Wu P; Dzamko N; Halliday GM; Kim WS
Acta Neuropathol Commun; 2022 Nov; 10(1):165. PubMed ID: 36376990
[TBL] [Abstract][Full Text] [Related]
22. [Prion-like Propagation of Pathological α-Synuclein in Vivo].
Masuda-Suzukake M; Hasegawa M
Yakugaku Zasshi; 2019; 139(7):1007-1013. PubMed ID: 31257247
[TBL] [Abstract][Full Text] [Related]
23. Anti-aggregation Effects of Phenolic Compounds on α-synuclein.
Ono K; Tsuji M; Yamasaki TR; Pasinetti GM
Molecules; 2020 May; 25(10):. PubMed ID: 32456274
[TBL] [Abstract][Full Text] [Related]
24. Stearoyl-CoA desaturase 5 (SCD5), a Δ-9 fatty acyl desaturase in search of a function.
Igal RA; Sinner DI
Biochim Biophys Acta Mol Cell Biol Lipids; 2021 Jan; 1866(1):158840. PubMed ID: 33049404
[TBL] [Abstract][Full Text] [Related]
25. Interactions of α-synuclein oligomers with lipid membranes.
Musteikytė G; Jayaram AK; Xu CK; Vendruscolo M; Krainer G; Knowles TPJ
Biochim Biophys Acta Biomembr; 2021 Apr; 1863(4):183536. PubMed ID: 33373595
[TBL] [Abstract][Full Text] [Related]
26. [Research progress of stearoyl-CoA desaturase-1 on obesity and non-alcoholic fatty liver disease Abstract].
Chen C; Hu YY; Feng Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Jul; 26(7):545-548. PubMed ID: 30317781
[TBL] [Abstract][Full Text] [Related]
27. Beta-synuclein occurs in vivo in lipid-associated oligomers and forms hetero-oligomers with alpha-synuclein.
Israeli E; Sharon R
J Neurochem; 2009 Jan; 108(2):465-74. PubMed ID: 19012742
[TBL] [Abstract][Full Text] [Related]
28. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
[TBL] [Abstract][Full Text] [Related]
29. PDGF-induced fibroblast growth requires monounsaturated fatty acid production by stearoyl-CoA desaturase.
Coomans de Brachène A; Dif N; de Rocca Serra A; Bonnineau C; Velghe AI; Larondelle Y; Tyteca D; Demoulin JB
FEBS Open Bio; 2017 Mar; 7(3):414-423. PubMed ID: 28286737
[TBL] [Abstract][Full Text] [Related]
30. Polyunsaturated fatty acids induce alpha-synuclein-related pathogenic changes in neuronal cells.
Assayag K; Yakunin E; Loeb V; Selkoe DJ; Sharon R
Am J Pathol; 2007 Dec; 171(6):2000-11. PubMed ID: 18055555
[TBL] [Abstract][Full Text] [Related]
31. The Oligomer Hypothesis in α-Synucleinopathy.
Ono K
Neurochem Res; 2017 Dec; 42(12):3362-3371. PubMed ID: 28828740
[TBL] [Abstract][Full Text] [Related]
32. Unveiling the MUFA-Cancer Connection: Insights from Endogenous and Exogenous Perspectives.
Guo Z; Bergeron KF; Lingrand M; Mounier C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373069
[TBL] [Abstract][Full Text] [Related]
33. Stearoyl-CoA desaturase is involved in the control of proliferation, anchorage-independent growth, and survival in human transformed cells.
Scaglia N; Igal RA
J Biol Chem; 2005 Jul; 280(27):25339-49. PubMed ID: 15851470
[TBL] [Abstract][Full Text] [Related]
34. Ellagic Acid Modulates Uninduced as well as Mutation and Metal-Induced Aggregation of α-Synuclein: Implications for Parkinson's Disease.
Meena VK; Kumar V; Karalia S; Garima ; Sundd M
ACS Chem Neurosci; 2021 Oct; 12(19):3598-3614. PubMed ID: 34506119
[TBL] [Abstract][Full Text] [Related]
35. The Parkinson's disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability.
Hallacli E; Kayatekin C; Nazeen S; Wang XH; Sheinkopf Z; Sathyakumar S; Sarkar S; Jiang X; Dong X; Di Maio R; Wang W; Keeney MT; Felsky D; Sandoe J; Vahdatshoar A; Udeshi ND; Mani DR; Carr SA; Lindquist S; De Jager PL; Bartel DP; Myers CL; Greenamyre JT; Feany MB; Sunyaev SR; Chung CY; Khurana V
Cell; 2022 Jun; 185(12):2035-2056.e33. PubMed ID: 35688132
[TBL] [Abstract][Full Text] [Related]
36. Altered fatty acid composition of dopaminergic neurons expressing alpha-synuclein and human brains with alpha-synucleinopathies.
Sharon R; Bar-Joseph I; Mirick GE; Serhan CN; Selkoe DJ
J Biol Chem; 2003 Dec; 278(50):49874-81. PubMed ID: 14507911
[TBL] [Abstract][Full Text] [Related]
37. β-Synuclein: An Enigmatic Protein with Diverse Functionality.
Hayashi J; Carver JA
Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053291
[TBL] [Abstract][Full Text] [Related]
38. Propagation of alpha-synuclein pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.
Uchihara T; Giasson BI
Acta Neuropathol; 2016 Jan; 131(1):49-73. PubMed ID: 26446103
[TBL] [Abstract][Full Text] [Related]
39. Parkinson's disease and alpha-synucleinopathies: from arising pathways to therapeutic challenge.
Miraglia F; Betti L; Palego L; Giannaccini G
Cent Nerv Syst Agents Med Chem; 2015; 15(2):109-16. PubMed ID: 25896035
[TBL] [Abstract][Full Text] [Related]
40. Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutants.
Watt KJC; Meade RM; Williams RJ; Mason JM
J Biol Chem; 2022 Dec; 298(12):102565. PubMed ID: 36208776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
